Addiction Medicine offentlig
[search 0]
Mer
Download the App!
show episodes
 
SEASON 2 will launch July 6th, 2023! Step up your knowledge on caring for patients with substance use disorders (SUD)! This show features addiction medicine experts who are dedicated to bringing you practice changing knowledge about substance use, and substance use disorders. We use expert interviews to demystify common addiction medicine topics, reduce stigma, and inspire listeners to be fierce advocates for all individuals who use substances. This mini-series is hosted by Doctors Carolyn C ...
  continue reading
 
An ideal opportunity for those interested in addiction medicine to get a closer look at the perspectives behind formal research articles. Podcasts offer insights into the experiences of the authors and researchers behind the great work and development in the field. Listening to their stories and thought processes helps listeners to connect with the experts behind the journal in a brand-new way. Hosted by Journal Podcast Editor, Shawn McNeil, MD
  continue reading
 
Loading …
show series
 
In episode 33 we discuss overdose risk and polypharmacy: opioids, benzodiazepines, antipsychotics, and gabapentinoids. Domzaridou E, Carr MJ, Millar T, Webb RT, Ashcroft DM. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mor…
  continue reading
 
In episode 32 we discuss an article about trazodone for sleep in people with opioid use disorder on buprenorphine. Piyush Goyal, Dheeraj Kattula, Ravindra Rao, Roshan Bhad, Ashwani Kumar Mishra, Anju Dhawan. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial. Drug and A…
  continue reading
 
31: We discuss an article about how naloxone training impacts IV drug use. Colledge-Frisby S, Rathnayake K, Nielsen S, et al. Injection Drug Use Frequency Before and After Take-Home Naloxone Training. JAMA Netw Open. 2023;6(8):e2327319. We also discuss gambling self-exclusion and which professions use the most drugs. From the Pennsylvania Gaming Co…
  continue reading
 
Quick summaries of Episodes 21-30. 21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder: Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder 22. Contingency Management for Coronary Artery Disease: High-risk Coronary Plaque Regression in Cash-based Conti…
  continue reading
 
The language used to describe people with substance use disorder impacts stigma and influences clinical decision-making. Host Dr. Shawn McNeil, MD discusses with Dr. Scott G. Weiner, MD the presence of stigmatizing language in clinical notes and detects patient- and provider-level differences. ----more---- Based on original research published in th…
  continue reading
 
The language used to describe people with substance use disorder impacts stigma and influences clinical decision-making. Host Dr. Shawn McNeil, MD discusses with Dr. Scott G. Weiner, MD the presence of stigmatizing language in clinical notes and detects patient- and provider-level differences. Based on original research published in the Journal of …
  continue reading
 
Keep saving lives by prescribing methadone and buprenorphine. Learn how initiations of each have changed in the era of high-potency synthetic opioids (HPSOs) like fentanyl and how to continue to provide person-centered care to people with opioid use disorder. We’re joined by Dr Melissa Weimer, @DrMelissaWeimer (Yale University). This episode is in …
  continue reading
 
In episode 30 we discuss an article about racial differences in the receipt of medications for opioid use disorder. Barnett ML, Meara E, Lewinson T, Hardy B, Chyn D, Onsando M, Huskamp HA, Mehrotra A, Morden NE. Racial Inequality in Receipt of Medications for Opioid Use Disorder. N Engl J Med. 2023 May 11;388(19):1779-1789. We also talk about opioi…
  continue reading
 
In episode 29 we discuss an article about using varenicline and counseling for vaping cessation.. Caponnetto, P., Campagna, D., Ahluwalia, J.S. et al. Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial. BMC Med 21, 220 (2023). In other vaping-related news: From NYSCSH: Vape pens tha…
  continue reading
 
Prevent opioid overdoses in your community! We discuss opioid overdose prevention and treatment so you can counsel patients who use substances on ways to decrease their risk of overdose. We discuss optimal ways to respond to hospital overdoses, ideal doses of naloxone, and how to monitor a patient experiencing an overdose clinically. We’re joined b…
  continue reading
 
Accelerate your knowledge on low-dose buprenorphine starts for individuals with opioid use disorder. We cover the physiology of how low-dose starts work, different 4-7 day protocols, and how to troubleshoot challenges patients may face. We’re joined by Dr. Eleasa Sokolski, MD (Oregon Health and Sciences University) and Amelia Goff, MSN, FNP (Oregon…
  continue reading
 
In episode 28 we discuss an article about pain and addiction recovery. Ajay Manhapra, Elina A. Stefanovics, Taeho Greg Rhee, Robert A. Rosenheck, Persistence of significant pain interference following substance use disorder remission: Negative association with psychosocial and physical recovery, Drug and Alcohol Dependence, Volume 232, 2022, 109339…
  continue reading
 
Gain insight into how racialized US drug policies, the War on Drugs, and media portrayals of substance use impact our patients in ongoing ways. Learn how you can take action and intentionally promote equity as a clinician! We’re joined by Dr Myra Mathis, @DrMyraMathis (University of Rochester Medical Center) Claim free CME for this episode at curbs…
  continue reading
 
Learn about long-acting injectable (LAI) buprenorphine for the treatment of opioid use disorder with Dr. Ken Lee, an addiction medicine provider in Canada. We go over the basics of using LAI buprenorphine, tips and tricks for troubleshooting with patients as well as newer protocols that Dr. Lee and his colleagues use. Claim free CME for this episod…
  continue reading
 
In episode 27 we discuss an article about the risk of developing opioid use disorder after the first opioid prescription. Kendler, K., Lönn, S., Ektor-Andersen, J., Sundquist, J., & Sundquist, K. (2022). Risk factors for the development of opioid use disorder after first opioid prescription: A Swedish national study. Psychological Medicine, 1-9. Fr…
  continue reading
 
Jumpstart your knowledge on how to counsel patients in primary care to help decrease their risk of returning to substance use! Learn how to help patients identify triggers, develop plans on how to navigate high-risk situations & so much more! We are joined by psychologist Dr. Eve Lasswell PsyD at the University of California San Diego! Claim free C…
  continue reading
 
Interpret urine drug tests (UDT) like a toxicologist! Learn how to approach interpreting positive opiates, opioids, and benzodiazepines in UDT. We discuss the nuances of interpreting UDT, false positives, and how to counsel a patient prior to ordering the test. We’re joined by Dr. Timothy Weigand @TwToxMD (University of Rochester Medical Center). C…
  continue reading
 
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study In episode 26 of Addiction Medicine: Beyond the Abstract, host Shawn McNeil, MD, is joined by Michael Incze, MD, MSEd. Dr. Incze is a primary care physician at the University of Utah Health Division of General Internal Medicine. He is board certified in …
  continue reading
 
26. We discuss a new conceptual model of addiction recovery. Pytell, J.D., Chander, G., Thakrar, A.P. et al. Pytell, J.D., Chander, G., Thakrar, A.P. et al. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J GEN INTERN MED 38, 1638–1646 (2023). We also talk about c…
  continue reading
 
Learn to take a trauma-informed criminal legal history, tailor your MOUD prescribing to meet the needs of patients impacted by the criminal legal system, and advocate for high-quality care in the carceral system and the community. We’re joined by Dr. Lisa Puglisi, @pugleesa (Yale University) Claim free CME for this episode at curbsiders.vcuhealth.o…
  continue reading
 
Distill the management of inpatient alcohol withdrawal down to its core with Dr. Shawn Cohen (@ShawnCohen_MD, Yale University). This episode is full of practical pearls, and we discuss the ins and outs of managing alcohol withdrawal in the hospital setting. Learn how to triage patients in the hospital, which benzodiazepines to select, the pathophys…
  continue reading
 
Crush chronic pain with buprenorphine. Learn how to assess chronic pain and opioid use disorder (OUD) in patients on long-term opioid therapy, when to consider buprenorphine, and how to make the switch. We’re joined by addiction medicine and pain management expert, Dr. William Becker (Yale School of Medicine). Claim free CME for this episode at cur…
  continue reading
 
Bring some heart to the care of people with IDU-IE. Learn how to provide person-centered care addressing both the acute infection and SUD and when/how to advocate for surgical treatment. We’re joined by Dr. Ayesha Appa @AyeshaAppaMD, (UCSF) Claim free CME for this episode at curbsiders.vcuhealth.org!…
  continue reading
 
25. We discuss an article about high-dose buprenorphine induction. Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. From NPR: Drugmaker Mallinckrodt may renege on $1.7 billion opioid settlement ---------- This podcast off…
  continue reading
 
Manage opioid use disorder in pregnancy. Learn how to counsel patients about the importance of medication and medication options, how to think about neonatal abstinence syndrome and recommendations for the postpartum period. We are joined by Dr. Mishka Terplan, on Twitter @do_less_harm (Friends Research Institute). Segments Intro, disclaimer: 0:00 …
  continue reading
 
Meet JAM Editor-in-Chief, David A. Fiellin, MD, FASAM Dr. Fiellin is an internist, board certified in addiction medicine. He is professor of Medicine and Emergency Medicine at Yale School of Medicine, and Public Health at Yale School of Public Health; vice chief of Faculty Affairs for the Department of Internal Medicine’s Section of General Interna…
  continue reading
 
Put on your Primary Care Cat-Hat We are thrilled to be back to kick off season 2! Carolyn Chan, MD (@CarolynAChan) soon to be at the University of Cincinnati, Shawn Cohen MD (@ShawnCohen_MD) at Yale University, Kenneth Morford MD at Yale University, and Natalie Stahl MD (@NanouTheNomad) at Greater Lawrence Family Health Center are back and on this …
  continue reading
 
24. We discuss updated data on the harms of smoking and the benefits of quitting. Thomson B, Emberson J, Lacey B, et al. Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults. JAMA Netw Open. 2022;5(10):e2231480. We also discuss the drug supply shift from heroin to fentanyl, and how California wan…
  continue reading
 
23. We discuss an article about the Eat-Sleep-Console approach to treat neonatal opioid withdrawal syndrome. Young LW, Ounpraseuth ST, et. al. ACT NOW Collaborative. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal. N Engl J Med. 2023 Apr 30. doi: 10.1056/NEJMoa2214470. Epub ahead of print. PMID: 37125831. We also share how…
  continue reading
 
22. Contingency Management for Coronary Artery Disease 22: We discuss an article about contingency management and the regression of coronary plaques in HIV+ cocaine users. Lai, Hong PhD; Bluemke, David A. MD; Fishman, Elliot K. MD; Gerstenblith, Gary MD; Celentano, David D. ScD; Treisman, Glenn MD; Foster, Parker MS; Mandler, Raul MD; Khalsa, Jag M…
  continue reading
 
21: We discuss an article about using short-acting opioids to treat opioid use disorder in the hospital. Thakrar, A.P., Uritsky, T.J., Christopher, C. et al. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder. Addict Sci Clin Pract 18, 13 (2023). We also discuss compuls…
  continue reading
 
What We Learned at ASAM2023 In this episode, we share what we learned at the 2023 American Society of Addiction Medicine Conference. Some links from the conference that you might like: Curbsiders Addiction Medicine Podcast ToxIC: Toxicology Investigators Consortium DrugsData from the Erowid Center CESAR: Center for Substance Use, Addiction, and Hea…
  continue reading
 
11-20 Round-up Super busy? Here are quick summaries of the last 10 articles. Article list: 11. Impact of wine bottle and glass sizes on wine consumption at home: a within- and between- households randomized controlled trial 12. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities 13. Prescription opioids and lon…
  continue reading
 
20. Targeted Naltrexone for Binge Drinking In episode 20 we discuss an article about taking naltrexone as needed to reduce binge drinking among sexual and gender minority men. Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, McLaughlin M, Jain J, Arenander J, Vittinghoff E, Batki S. Targeted Oral Naltrexone for Mild to Moderate Alcohol Us…
  continue reading
 
19. Patients’ Goals in Treatment In episode 19 we discuss an article about what is most important to patients in treatment for opioid use disorder. Reed, M.K., Smith, K.R., Ciocco, F. et al. Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program. Subst Abuse Treat Prev…
  continue reading
 
In episode 18 we discuss the Hepatitis C Real Option (HERO) Study about two different models of HCV treatment in people who inject drugs. Litwin AH, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo M, Arnsten J, Meissner P, Karasz A, Mckee MD, Ward JW, Johnson N, Pericot-Valverde I, Agyemang L, Stein ES, Thomas A, Borsuk C, …
  continue reading
 
In episode 17 we discuss buprenorphine-naloxone vs. buprenorphine alone in pregnancy. Perry, Briana N. MD; Vais, Simone MD; Boateng, Jeffery O. MBchB, MPH; Jain, Mayuri MPH; Wachman, Elisha M. MD; Saia, Kelley A. MD. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy. Journal of Addiction Medicine 16(6):p …
  continue reading
 
16. Treating Opioid Use Disorder in Jail In episode 16 we discuss an article about in-jail medication for opioid use disorder and recidivism. Elizabeth A. Evans, Donna Wilson, Peter D. Friedmann. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence, Volume 231, 2022, 109254, ISSN 0376-8…
  continue reading
 
In episode 15 we discuss buprenorphine vs. methadone in pregnancy. E.A. Suarez, K.F. Huybrechts, L. Straub, S. Hernández‑Díaz, H.E. Jones, H.S. Connery, J.M. Davis, K.J. Gray, B. Lester, M. Terplan, H. Mogun, and B.T. Bateman. Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy. N Engl J Med 2022; 387:2033-2044. Bruzelius E, Martins…
  continue reading
 
In episode 14 we discuss the connection between early life trauma, depression, anxiety, stress, and opioid use disorder. Effects of Early Life Trauma on Risks for Adult Opioid Use Disorder Are Mediated by Stress and Occur Independent of Depression and Anxiety. Dunn, Kelly E. PhD, MBA; Turner, Gavin M. BS; Oswald, Lynn M. PhD. Journal of Addiction M…
  continue reading
 
In episode 13 we discuss opioids and cognitive changes in older adults. Warner, NS, Hanson, AC, Schulte, PJ, Habermann, EB, Warner, DO, Mielke, MM. Prescription opioids and longitudinal changes in cognitive function in older adults: A population-based observational study. J Am Geriatr Soc. 2022; 1- 12. doi:10.1111/jgs.18030 https://agsjournals.onli…
  continue reading
 
In episode 12 we discuss overdoses related to methamphetamine and opioid use in rural areas. Korthuis PT, Cook RR, Foot CA, et al. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities. JAMA Netw Open. 2022;5(8):e2226544. doi:10.1001/jamanetworkopen.2022.26544 August 2022 Rural Opioid Initiative ---------- We als…
  continue reading
 
In episode 11 we discuss an article about the impact of wine bottle and glass size on consumption. Mantzari, E, Ventsel, M, Ferrar, J, Pilling, MA, Hollands, GJ, Marteau, TM. Impact of wine bottle and glass sizes on wine consumption at home: a within- and between- households randomized controlled trial. Addiction. 2022. ---------- We discuss non-ab…
  continue reading
 
Short on time? In this episode we give you quick summaries of articles 1-10. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder Association of Dose Tapering With Overdose or Mental Healt…
  continue reading
 
In episode 10 we discuss an article about buprenorphine tapering. Bozinoff N, Men S, Kurdyak P, Selby P, Gomes T. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper. JAMA Netw Open. 2022;5(9):e2234168. ---------- Take a look at Riggs, KR, DeRussy, AJ, Leisch, L, et al. Sensitivity of health records for self-re…
  continue reading
 
In episode 9 we discuss psilocybin for treating alcohol use disorder. Bogenschutz MP, Ross S, Bhatt S, et al. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(10):953–962. ---------- We talk abo…
  continue reading
 
In episode 8 we discuss the article about opioid tapering and discontinuation, and the risks of suicide and overdose. Larochelle MR, Lodi S, Yan S, Clothier BA, Goldsmith ES, Bohnert ASB. Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term …
  continue reading
 
In Episode 7 we discuss treating opioid use disorder with co-occurring polysubstance use. Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use. JAMA Netw Open. 2022;5(5):e2211363. 2022 Aug 3. We also discuss the Society of H…
  continue reading
 
Tackle smoking cessation by offering your patients evidence-based treatment options. We discuss pharmacotherapy, mindfulness, and practical tips on how to manage short-acting nicotine replacement therapy to help your patient stop smoking. We are joined by Dr. Panagis Galiatsatos from Hopkins (@Panagis21).…
  continue reading
 
In episode 6 we discuss a benzodiazepine-sparing alcohol withdrawal protocol. Smith JT, Sage M, Szeto H, et al. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System. JAMA Netw Open. 2022;5(2):e220158. 2022 Feb 2. We also discuss long-term outcomes from a primary-care based MAT cl…
  continue reading
 
Loading …

Snabbguide